![Nader Motamedy](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Posizioni attive di Nader Motamedy
Società | Posizione | Inizio | Fine |
---|---|---|---|
Safar Partners LLC
![]() Safar Partners LLC Investment ManagersFinance Safar Partners LLC (Safar Partners) is a venture capital firm founded in 2019 by Nader Motamedy. The firm is headquartered in Cambridge, Massachusetts. | Fondatore | 01/01/2019 | - |
Investitore di Private Equity | 01/01/2019 | - | |
Aramis Biosciences, Inc.
![]() Aramis Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Aramis Biosciences is a clinical-stage immuno-ophthalmology biopharmaceutical company based in Medfield, MA. Aramis Biosciences is committed to developing disease-modifying therapy for ocular surface disease, starting with dry eye disease. The company's lead product candidate, A197, is a novel, first-in-class, topical immunomodulatory agent currently in a phase II clinical proof of concept for the treatment of dry eye disease. The company was founded in 2018 by Sunil Chauhan, Reza Dana, and the CEO is David S. Tierney. Aramis Biosciences was founded by leading experts in the fields of corneal disorders, ocular inflammation, and immunology from the Schepens Eye Research Institute of Mass Eye and Ear and the Department of Ophthalmology at Harvard Medical School, with support from Safar Partners, Dompé Farmaceutici S.p.A., and a leader in ophthalmic pharmaceuticals. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Nader Motamedy
Precedenti posizioni note di Nader Motamedy
Società | Posizione | Inizio | Fine |
---|---|---|---|
Caspian Private Equity LLC
![]() Caspian Private Equity LLC Investment ManagersFinance Caspian Private Equity LLC is a private equity firm founded in 2008.The firm is headquartered in New York. | Amministratore Delegato | 01/01/2000 | 13/12/2018 |
Caspian Capital Management LLC
![]() Caspian Capital Management LLC Investment ManagersFinance Founded in 2000, Caspian Capital Management LLC is a registered investment advisor located in New York City. They are a wholly-owned subsidiary of Natixis Global Asset Management SA. The firm manages alternative fixed-income, fund-of-funds, private equity and real estate portfolios for institutional clients. | Portfolio Manager-Fixed Income | 09/02/2011 | - |
Statistiche
Distribuzione geografica
Stati Uniti | 5 |
Posizioni
Portfolio Manager-Fixed Income | 1 |
Chief Executive Officer | 1 |
Founder | 1 |
Settori
Finance | 4 |
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 4 |
---|---|
Caspian Capital Management LLC
![]() Caspian Capital Management LLC Investment ManagersFinance Founded in 2000, Caspian Capital Management LLC is a registered investment advisor located in New York City. They are a wholly-owned subsidiary of Natixis Global Asset Management SA. The firm manages alternative fixed-income, fund-of-funds, private equity and real estate portfolios for institutional clients. | Finance |
Caspian Private Equity LLC
![]() Caspian Private Equity LLC Investment ManagersFinance Caspian Private Equity LLC is a private equity firm founded in 2008.The firm is headquartered in New York. | Finance |
Safar Partners LLC
![]() Safar Partners LLC Investment ManagersFinance Safar Partners LLC (Safar Partners) is a venture capital firm founded in 2019 by Nader Motamedy. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Aramis Biosciences, Inc.
![]() Aramis Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Aramis Biosciences is a clinical-stage immuno-ophthalmology biopharmaceutical company based in Medfield, MA. Aramis Biosciences is committed to developing disease-modifying therapy for ocular surface disease, starting with dry eye disease. The company's lead product candidate, A197, is a novel, first-in-class, topical immunomodulatory agent currently in a phase II clinical proof of concept for the treatment of dry eye disease. The company was founded in 2018 by Sunil Chauhan, Reza Dana, and the CEO is David S. Tierney. Aramis Biosciences was founded by leading experts in the fields of corneal disorders, ocular inflammation, and immunology from the Schepens Eye Research Institute of Mass Eye and Ear and the Department of Ophthalmology at Harvard Medical School, with support from Safar Partners, Dompé Farmaceutici S.p.A., and a leader in ophthalmic pharmaceuticals. | Health Technology |
- Borsa valori
- Insiders
- Nader Motamedy
- Esperienza